SUSD2-IL-2 receptor interaction hinders antitumoral CD8<sup>+</sup> T-cell activity: Implications for cancer immunotherapy.

Moreno-Sanchez, Pilar M; Scafidi, Andrea; Salvato, Ilaria

SUSD2-IL-2 receptor interaction hinders antitumoral CD8⁺ T-cell activity: Implications for cancer immunotherapy.

Moreno-Sanchez, Pilar M; Scafidi, Andrea; Salvato, Ilaria.

Afiliação

Moreno-Sanchez PM; NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg City, Luxembourg.
Scafidi A; Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, Belvaux, Luxembourg.
Salvato I; Faculty of Science, Technology and Medicine (FSTM), University of Luxembourg, Belvaux, Luxembourg.

Allergy ; 78(11): 3035-3037, 2023 11.

Article em En | MEDLINE | ID: mdl-37401528

Assuntos

Neoplasias; Receptores de Interleucina-2; Humanos; Linfócitos T CD8-Positivos; Neoplasias/terapia; Imunoterapia; Imunoterapia Adotiva; Glicoproteínas de Membrana

Palavras-chave

CAR T cells; CD8+ T cells; IL-2; SUSD2; cancer immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-2 / Neoplasias Limite: Humans Idioma: En Revista: Allergy Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Luxemburgo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google